page 1
page 2
page 3
page 4
page 5
page 6
page 7
page 8
page 9
page 10
page 11
page 12
page 13
page 14
page 15
page 16
page 17
page 18
page 19
page 20
page 21
page 22
page 23
page 24
page 25
page 26
page 27
page 28
page 29
page 30
page 31
page 32
page 33
page 34
page 35
page 36
page 37
page 38
page 39
page 40
page 41
page 42
page 43
page 44
page 45
page 46
page 47
page 48
page 49
page 50
page 51
page 52
page 53
page 54
page 55
page 56
page 57
page 58
page 59
page 60
page 61
page 62
page 63
page 64
page 65
page 66
page 67
page 68
page 69
page 70
page 71
page 72
page 73
page 74
page 75
page 76
page 77
page 78
page 79

56Spire Healthcare Annual Review 2010Spire Healthcare Limited PartnershipNotes to the financial statementsFor the year ended 31 December 20109. Intangible assets continuedThe fair value of the assets and liabilities acquired via business combinations in the year were as follows:Acquiree's book value£000Fair value adjustment£000Acquisition amount£000Leasehold properties1,801(5)1,796Equipment464(63)401Stocks271-271Debtors & prepayments381-381Cash130-130Deferred tax asset-5555Creditors, accruals and other liabilities(360)(313)(673)Net identifiable assets and liabilities2,687(326)2,361Goodwill3,739Total purchase price for operating assets6,100Impairment testingGoodwill brought forward arose principally from three separate acquisitions and has been allocated to three cash-generating units. In 2007 £422.5 million was allocated to Spire 1 and in 2008 £82.6 million was allocated to Spire 2 and £6 million to Spire Thames Valley Hospital.In 2010 goodwill of £3.7 million arose from the acquisitions of London Fertility Centre, The Richard Villar Practice and The London Cognitive Behaviour Therapy Centres, further details of which are provided in note 27.The recoverable amount of each cash-generating unit was calculated as at 31 December 2010 by reference to its value in use, which in each case exceeded its carrying value and therefore no impairment provision is required. In order to evaluate the value in use, management utilised the cash flows from the 2010 three-year plan approved by the Board of Directors, which was extended to cover the five year period 2011-2015.Management identified a number of key assumptions over the period of the forecasts which determine the run rate of earnings before interest, tax, depreciation and amortisation (EBITDA). Revenue growth is projected to average 5.5% for the five year period and is impacted by an interaction of a number of elements of the operating model, including pricing trends, volume growth and the mix and complexity of discharges. These variables are interdependent and the forecast cash flows reflect management's expectations based on current market trends. Cost assumptions are consistent with the Group's historic track record, after taking account of a conservative level of inflationary increase, assuming that headline inflation is at 2.5% and delivering further efficiencies that can be achieved as the Group continues to build scale and volume.A long-term growth rate of 2.25% (2009: 2.25%) has been applied to cash flows beyond 2015, which is based on historic growth rates achieved by the sector, which have typically exceeded RPI. Pre-tax discount rates were based on the capital asset pricing model, utilising a sector-specific Beta in arriving at the equity premium and cost of debt based on current bank lending rates. For each cash-generating unit, a specific pre-tax discount rate was calculated to reflect the profile of cash flows inherent to that specific cash-generating unit and these were in the range of 10.5%-11.0% (2009: 10.5% -11.3%).The recoverable amount from each acquisition is based on cash flow forecasts that reflect the assumptions stated above. As at the balance sheet date, it is not considered to be reasonably possible that circumstances will change so that the key assumptions made in assessing the recoverable amount relating to each of the acquisitions will be revised to the point where the goodwill equals the carrying amount.

57Spire Healthcare Limited Partnership10. Property, plant and equipmentFreehold property£000Long leasehold property£000Equipment£000Assets in the course of construction£000Total£000Cost At 1 January 20091,155,538 203,173 109,371 10,868 1,478,950 Additions11,319 4,011 27,864 23,794 66,988 Reclassifications3,922 - - (3,922) - Disposals(619) - (12,336) - (12,955)At 31 December 2009 and 1 January 2010 1,170,160 207,184 124,899 30,740 1,532,983 Additions1,046 44,707 29,290 2,414 77,457 Acquired in a business combination - 1,796 401 - 2,197 Reclassifications18,360 14,452 (2)(32,810) - Disposals(7) - (74) - (81)At 31 December 2010 1,189,559 268,139 154,514 344 1,612,556 DepreciationAt 1 January 200932,587 3,571 18,363 - 54,521 Charge for the year23,405 3,878 13,748 - 41,031 Reclassifications373 - (373) - - Disposals(454) - (12,000) - (12,454)At 31 December 2009 and 1 January 2010 55,911 7,449 19,738 - 83,098 Charge for the year20,982 8,530 16,288 - 45,800 Disposals(7) - (26) - (33)At 31 December 2010 76,886 15,979 36,000 - 128,865 Net Book ValueAt 31 December 2010 1,112,673 252,160 118,514 344 1,483,691 At 31 December 2009 1,114,249 199,735 105,161 30,740 1,449,885 Included in the net book value of land and buildings above is £31.8 million (2009: £nil) relating to assets held under finance leases on which there was a depreciation charge of £1.0 million (2009: £nil) in the year.